Molecular testing in epidermolysis bullosa

Daniele Castiglia, Giovanna Zambruno

Research output: Contribution to journalArticlepeer-review


The development of DNA technology and improved knowledge of the structure and function of the human genome have led to the identification of the causative genes responsible for the different forms of epidermolysis bullosa (EB) and provided the opportunity to determine the precise location and type of mutations present in EB patients, allowing diagnosis of this disease at the level of the defective gene itself. The large genetic heterogeneity of EB, however, precludes the direct use of molecular testing for EB diagnosis. In addition, only a few diagnostic or research laboratories in the world are equipped to perform mutational screening, which is still labor intensive and associated with considerable costs, because most mutations are unique to one or a few families. This article reviews the most popular methods used in EB molecular analysis.

Original languageEnglish
Pages (from-to)223-229
Number of pages7
JournalDermatologic Clinics
Issue number2
Publication statusPublished - Apr 2010


  • DNA sequencing
  • Epidermolysis bullosa
  • Mismatch screening
  • Mutation detection

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Molecular testing in epidermolysis bullosa'. Together they form a unique fingerprint.

Cite this